60
Participants
Start Date
August 31, 2014
Primary Completion Date
August 31, 2017
Study Completion Date
August 31, 2017
MMFS-202-302
"Active ingredient: L-Threonic acid Magnesium salt.~1 g (2 pills) by mouth once daily in the evening for 9 weeks~Drug: MMFS-302 Active ingredient: L-Threonic Acid Magnesium Salt~1 g (2 pills) by mouth once daily in the morning for 9 weeks"
Placebo
Two tablets by mouth in the morning, and two tablets by mouth in the evening, daily for 9 weeks.
Northwestern University Psychiatric Clinical Research Program, Chicago
Collaborators (2)
Neurocentria, Inc.
INDUSTRY
Brain & Behavior Research Foundation
OTHER
Northwestern University
OTHER